These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12180714)

  • 1. Not yet time to change the guidelines for monitoring methotrexate liver toxicity: they have served us well.
    Kremer JM
    J Rheumatol; 2002 Aug; 29(8):1590-2. PubMed ID: 12180714
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yazici Y; Erkan D; Paget SA
    J Rheumatol; 2002 Aug; 29(8):1586-9. PubMed ID: 12180713
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 5. Transaminitis and neutropenia are rare in patients on methotrexate: evidence from a large cohort of inflammatory arthritis patients.
    Malley T; Corfield G; Fung P; Heneghan D; Kitchen J
    Rheumatology (Oxford); 2019 Nov; 58(11):2061-2062. PubMed ID: 31081042
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate therapy, rheumatoid arthritis, and life-threatening liver complications: should we be monitoring more closely?
    Tugnet N; Cooper SC; Douglas KM
    Scand J Rheumatol; 2012 Mar; 41(2):163-4. PubMed ID: 22420415
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methotrexate].
    Rau R
    Z Rheumatol; 2016 Aug; 75(6):599-603. PubMed ID: 27365027
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate hepatotoxicity.
    West SG
    Rheum Dis Clin North Am; 1997 Nov; 23(4):883-915. PubMed ID: 9361160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Lynch M; Kirby B
    Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of methotrexate-associated hepatotoxicity.
    Bath RK; Brar NK; Forouhar FA; Wu GY
    J Dig Dis; 2014 Oct; 15(10):517-24. PubMed ID: 25139707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events.
    Yazici Y; Erkan D; Paget SA
    Arthritis Rheum; 2003 Oct; 48(10):2769-72. PubMed ID: 14558081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate use and alcohol.
    Price S; James C; Deighton C
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S114-6. PubMed ID: 21044443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
    Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
    Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
    Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.
    Hassan W
    Ann Rheum Dis; 1996 May; 55(5):273-5. PubMed ID: 8660097
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient Elastography for Monitoring for Hepatotoxicity in Rheumatoid Arthritis Patients on Long-term Methotrexate.
    Wade SD; Yoshida EM; Carruthers MN; Weinblatt ME
    J Clin Rheumatol; 2021 Jun; 27(4):e131-e134. PubMed ID: 30106792
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methotrexate toxicity. Myths and facts].
    Keysser G
    Z Rheumatol; 2011 Feb; 70(2):108-13. PubMed ID: 21267730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
    Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.